Wound Care Market Size, Share & Trends Analysis Report By Application (Chronic, Acute), By End-use (Hospitals, Nursing Homes), By Product (Advanced, Traditional), By Distribution Channel, By Mode of Purchase, And Segment Forecasts, 2024 - 2030
Wound Care Market Growth & Trends
The global wound care market size is projected to reach USD 29.57 billion by 2030, registering a CAGR of 4.17% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising volume of surgical procedures, a rapidly aging population, as well as growing number of diabetic patients, are among the major factors driving market’s growth. For instance, according to Ageing Asia, as of 2019, more than 139 million people, i.e., about 10% of India’s total population, were aged over 60 years. This number is expected to increase to 19.5% by 2050. The geriatric population is more susceptible to wounds, and thus, with an increasing geriatric population, the market is anticipated to expand during the forecast period. The market has seen significant technological advancements in recent years, leading to the development of new and innovative products for treating various types of wounds.
Naturally occurring proteins, which stimulate cell growth and division, can be used in wound care to promote healing and tissue regeneration. For example, platelet-derived growth factor (PDGF) is effective in promoting the healing of chronic wounds. 3D printing technology has revolutionized the production of custom-made wound care products, such as prosthetic limbs, orthotics, and wound dressings. Many leading manufacturers are undergoing strategic initiatives, such as product launches, partnerships, and geographic expansions, which may help them capitalize on the rising product demand. For instance, Human Biosciences planned on launching two new wound care products in the Indian market. The launch of these products is expected to help the company capture the post-pandemic market in India. Similar initiatives by other players are anticipated to boost market growth.
Wound Care Market Report Highlights
- The advanced wound dressing product segment dominated the market with a share of 34.8% in 2023 owing to the advantages offered by these dressings over their traditional counterparts
- The chronic wound application segment dominated the market with a share of 59.8% in 2023 due to increased cases of diabetic foot ulcers and pressure ulcers across the globe
- The hospital end-use segment led the market on account of the increasing number of surgical site infections (SSIs). On the other hand, the home care segment is anticipated to witness the fastest CAGR from 2024 to 2030
- Based on mode of purchase, the prescribed segment dominated the market with a share of 62.7% in 2023
- The institutional sales distribution channel segment dominated the market. However, the retail sales segment is anticipated to witness the fastest CAGR of 4.55% from 2024 to 2030
- North America was the dominant regional market with a share of 45.4% in 2023 owing to technological advancements and a high volume of surgical procedures
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. End-use
- 1.1.4. Mode of purchase
- 1.1.5. Distribution channel
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR’s internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. End-use outlook
- 2.2.4. Mode of purchase outlook
- 2.2.5. Distribution channel outlook
- 2.3. Competitive Insights
- Chapter 3. Wound Care Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of chronic diseases and conditions affecting wound healing capabilities
- 3.2.1.2. Introduction of innovative and advanced wound products
- 3.2.1.3. Rising geriatric population
- 3.2.1.4. Increasing number of ambulatory surgical centers (ASCs)
- 3.2.1.5. Increasing number of accidents
- 3.2.2. Market restraint analysis
- 3.2.2.1. Delayed Diagnosis and lower treatment rates in emerging nations
- 3.2.2.2. High cost of advanced wound care products and chronic wound treatments
- 3.2.2.3. Stringent manufacturing policies
- 3.2.3. Market opportunity analysis
- 3.3. U.S. Wound Care Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.3. Covid-19 Impact Analysis
- Chapter 4. Wound Care Market: Product Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Advanced wound dressing
- 4.1.2. Surgical wound care
- 4.1.3. Traditional wound care
- 4.1.4. Wound therapy devices
- 4.2. Product Market Share, 2018 & 2030
- 4.3. Segment Dashboard
- 4.4. U.S. Wound Care Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
- 4.5.1. Advanced wound dressing
- 4.5.1.1. Advanced wound dressing market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.1.2. Foam dressings
- 4.5.1.2.1. Foam dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.1.3. Hydrocolloid dressings
- 4.5.1.3.1. Hydrocolloid dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.1.4. Film dressings
- 4.5.1.4.1. Film dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.1.5. Alginate dressings
- 4.5.1.5.1. Alginate dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.1.6. Hydrogel dressings
- 4.5.1.6.1. Hydrogel dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.1.7. Collagen dressings
- 4.5.1.7.1. Collagen dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.1.8. Other advanced dressings
- 4.5.1.8.1. Other advanced dressings market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Surgical wound care
- 4.5.2.1. Surgical wound care market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2.2. Sutures & staples
- 4.5.2.2.1. Sutures & staples market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2.3. Tissue adhesives & sealants
- 4.5.2.3.1. Tissue adhesives & sealants market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2.4. Anti-infective dressing
- 4.5.2.4.1. Anti-infective dressing market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3. Traditional wound care
- 4.5.3.1. Traditional wound care market estimates and forecast 2018 to 2030s, (USD Million)
- 4.5.3.2. Medical tapes
- 4.5.3.2.1. Medical tapes market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3.3. Cotton
- 4.5.3.3.1. Cotton market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3.4. Bandages
- 4.5.3.4.1. Bandages market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3.5. Gauzes
- 4.5.3.5.1. Gauzes market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3.6. Sponges
- 4.5.3.6.1. Sponges market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3.7. Cleansing agents
- 4.5.3.7.1. Cleansing agents market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.4. Wound therapy devices
- 4.5.4.1. Wound therapy devices market estimates and forecast 2018 to 2030s, (USD Million)
- 4.5.4.2. Negative pressure wound therapy
- 4.5.4.2.1. Negative pressure wound therapy market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.4.3. Oxygen and hyperbaric oxygen equipment
- 4.5.4.3.1. Oxygen and hyperbaric oxygen equipment market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.4.4. Electric stimulation devices
- 4.5.4.4.1. Electric stimulation devices market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.4.5. Pressure relief devices
- 4.5.4.5.1. Pressure relief devices market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.4.6. Others
- 4.5.4.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 5. Wound Care Market: Application Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Acute Wounds
- 5.1.2. Chronic Wounds
- 5.2. Application Market Share, 2018 & 2030
- 5.3. Segment Dashboard
- 5.4. U.S. Wound Care Market by Application Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2023 to 2030 for the following
- 5.5.1. Acute Wounds
- 5.5.1.1. Acute wounds market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.1.2. Surgical & traumatic wounds
- 5.5.1.2.1. Surgical & traumatic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.1.3. Burns
- 5.5.1.3.1. Burns market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Chronic Wounds
- 5.5.2.1. Chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2.2. Diabetic foot ulcers
- 5.5.2.2.1. Diabetic foot ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2.3. Pressure ulcers
- 5.5.2.3.1. Pressure ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2.4. Venous leg ulcers
- 5.5.2.4.1. Venous leg ulcers market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2.5. Others chronic wounds
- 5.5.2.5.1. Others chronic wounds market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 6. Wound Care Devices: End-use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Specialty clinics
- 6.1.3. Home Healthcare
- 6.1.4. Physician’s office
- 6.1.5. Nursing homes
- 6.1.6. Others
- 6.2. End Use Market Share, 2018 & 2030
- 6.3. Segment Dashboard
- 6.4. U.S. Wound Care Market by End-use Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Hospitals
- 6.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.2. Specialty clinics
- 6.5.2.1. Specialty clinics centers market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.3. Home healthcare
- 6.5.3.1. Home healthcare market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.4. Physician’s office
- 6.5.4.1. Physician’s office market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.5. Nursing Homes
- 6.5.5.1. Nursing homes market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.6. Others
- 6.5.6.1. Others market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 7. Wound Care Market: Mode of Purchase Estimates & Trend Analysis
- 7.1. Definitions and Scope
- 7.1.1. Prescribed
- 7.1.2. Non-prescribed (OTC)
- 7.2. Mode of Purchase Market Share, 2018 & 2030
- 7.3. Segment Dashboard
- 7.4. U.S. Wound Care Market by Mode of Purchase Outlook
- 7.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 7.5.1. Prescribed
- 7.5.1.1. Prescribed market estimates and forecast 2018 to 2030 (USD Million)
- 7.5.2. Non-prescribed (OTC)
- 7.5.2.1. Non-prescribed (OTC) market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 8. Wound Care Market: Distribution Channel Estimates & Trend Analysis
- 8.1. Definitions and Scope
- 8.1.1. Institutional sales
- 8.1.2. Retail sales
- 8.2. Distribution Channel Market Share, 2018 & 2030
- 8.3. Segment Dashboard
- 8.4. U.S. Wound Care Market by Distribution Channel Outlook
- 8.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 8.5.1. Institutional sales
- 8.5.1.1. Institutional sales market estimates and forecast 2018 to 2030 (USD Million)
- 8.5.2. Retail sales
- 8.5.2.1. Retail sales market estimates and forecast 2018 to 2030 (USD Million)
- Chapter 9. Wound Care Market: Regional Estimates & Trend Analysis
- 9.1. Regional market share analysis, 2023 & 2030
- 9.2. Regional Market Dashboard
- 9.3. Global Regional Market Snapshot
- 9.4. Regional Market Share and Leading Players, 2023
- 9.4.1. North America
- 9.4.2. Europe
- 9.4.3. Asia Pacific
- 9.4.4. Latin America
- 9.4.5. Middle East and Africa
- 9.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
- 9.6. North America
- 9.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 9.6.2. U.S.
- 9.6.2.1. Key country dynamics
- 9.6.2.2. Competitive scenario
- 9.6.2.3. Regulatory framework
- 9.6.2.4. Reimbursement scenario
- 9.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
- 9.6.3. Canada
- 9.6.3.1. Key country dynamics
- 9.6.3.2. Competitive scenario
- 9.6.3.3. Regulatory framework
- 9.6.3.4. Reimbursement scenario
- 9.6.3.5. Canada market estimates and forecasts, 2018 - 2030
- 9.7. Europe
- 9.7.1. UK
- 9.7.1.1. Key country dynamics
- 9.7.1.2. Competitive scenario
- 9.7.1.3. Regulatory framework
- 9.7.1.4. Reimbursement scenario
- 9.7.1.5. UK market estimates and forecasts, 2018 - 2030
- 9.7.2. Germany
- 9.7.2.1. Key country dynamics
- 9.7.2.2. Competitive scenario
- 9.7.2.3. Regulatory framework
- 9.7.2.4. Reimbursement scenario
- 9.7.2.5. Germany market estimates and forecasts, 2018 - 2030
- 9.7.3. France
- 9.7.3.1. Key country dynamics
- 9.7.3.2. Competitive scenario
- 9.7.3.3. Regulatory framework
- 9.7.3.4. Reimbursement scenario
- 9.7.3.5. France market estimates and forecasts, 2018 - 2030
- 9.7.4. Italy
- 9.7.4.1. Key country dynamics
- 9.7.4.2. Competitive scenario
- 9.7.4.3. Regulatory framework
- 9.7.4.4. Reimbursement scenario
- 9.7.4.5. Italy market estimates and forecasts, 2018 - 2030
- 9.7.5. Spain
- 9.7.5.1. Key country dynamics
- 9.7.5.2. Competitive scenario
- 9.7.5.3. Regulatory framework
- 9.7.5.4. Reimbursement scenario
- 9.7.5.5. Spain market estimates and forecasts, 2018 - 2030
- 9.7.6. Denmark
- 9.7.6.1. Key country dynamics
- 9.7.6.2. Competitive scenario
- 9.7.6.3. Regulatory framework
- 9.7.6.4. Reimbursement scenario
- 9.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
- 9.7.7. Sweden
- 9.7.7.1. Key country dynamics
- 9.7.7.2. Competitive scenario
- 9.7.7.3. Regulatory framework
- 9.7.7.4. Reimbursement scenario
- 9.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
- 9.7.8. Norway
- 9.7.8.1. Key country dynamics
- 9.7.8.2. Competitive scenario
- 9.7.8.3. Regulatory framework
- 9.7.8.4. Reimbursement scenario
- 9.7.8.5. Norway market estimates and forecasts, 2018 - 2030
- 9.8. Asia Pacific
- 9.8.1. Japan
- 9.8.1.1. Key country dynamics
- 9.8.1.2. Competitive scenario
- 9.8.1.3. Regulatory framework
- 9.8.1.4. Reimbursement scenario
- 9.8.1.5. Japan market estimates and forecasts, 2018 - 2030
- 9.8.2. India
- 9.8.2.1. Key country dynamics
- 9.8.2.2. Competitive scenario
- 9.8.2.3. Regulatory framework
- 9.8.2.4. Reimbursement scenario
- 9.8.2.5. India market estimates and forecasts, 2018 - 2030
- 9.8.3. China
- 9.8.3.1. Key country dynamics
- 9.8.3.2. Competitive scenario
- 9.8.3.3. Regulatory framework
- 9.8.3.4. Reimbursement scenario
- 9.8.3.5. China market estimates and forecasts, 2018 - 2030
- 9.8.4. South Korea
- 9.8.4.1. Key country dynamics
- 9.8.4.2. Competitive scenario
- 9.8.4.3. Regulatory framework
- 9.8.4.4. Reimbursement scenario
- 9.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
- 9.8.5. Australia
- 9.8.5.1. Key country dynamics
- 9.8.5.2. Competitive scenario
- 9.8.5.3. Regulatory framework
- 9.8.5.4. Reimbursement scenario
- 9.8.5.5. Australia market estimates and forecasts, 2018 - 2030
- 9.8.6. Thailand
- 9.8.6.1. Key country dynamics
- 9.8.6.2. Competitive scenario
- 9.8.6.3. Regulatory framework
- 9.8.6.4. Reimbursement scenario
- 9.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
- 9.9. Latin America
- 9.9.1. Brazil
- 9.9.1.1. Key country dynamics
- 9.9.1.2. Competitive scenario
- 9.9.1.3. Regulatory framework
- 9.9.1.4. Reimbursement scenario
- 9.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
- 9.9.2. Mexico
- 9.9.2.1. Key country dynamics
- 9.9.2.2. Competitive scenario
- 9.9.2.3. Regulatory framework
- 9.9.2.4. Reimbursement scenario
- 9.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
- 9.9.3. Argentina
- 9.9.3.1. Key country dynamics
- 9.9.3.2. Competitive scenario
- 9.9.3.3. Regulatory framework
- 9.9.3.4. Reimbursement scenario
- 9.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
- 9.10. MEA
- 9.10.1. South Africa
- 9.10.1.1. Key country dynamics
- 9.10.1.2. Competitive scenario
- 9.10.1.3. Regulatory framework
- 9.10.1.4. Reimbursement scenario
- 9.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
- 9.10.2. Saudi Arabia
- 9.10.2.1. Key country dynamics
- 9.10.2.2. Competitive scenario
- 9.10.2.3. Regulatory framework
- 9.10.2.4. Reimbursement scenario
- 9.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
- 9.10.3. UAE
- 9.10.3.1. Key country dynamics
- 9.10.3.2. Competitive scenario
- 9.10.3.3. Regulatory framework
- 9.10.3.4. Reimbursement scenario
- 9.10.3.5. UAE market estimates and forecasts, 2018 - 2030
- 9.10.4. Kuwait
- 9.10.4.1. Key country dynamics
- 9.10.4.2. Competitive scenario
- 9.10.4.3. Regulatory framework
- 9.10.4.4. Reimbursement scenario
- 9.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
- Chapter 10. Competitive Landscape
- 10.1. Recent Developments & Impact Analysis, By Key Market Participants
- 10.2. Company/Competition Categorization
- 10.2.1. Innovators
- 10.3. Vendor Landscape
- 10.3.1. List of key distributors and channel partners
- 10.3.2. Key customers
- 10.3.3. Key company market share analysis, 2023
- 10.3.4. Smith & Nephew PLC
- 10.3.4.1. Company overview
- 10.3.4.2. Financial performance
- 10.3.4.3. Product benchmarking
- 10.3.4.4. Strategic initiatives
- 10.3.5. Mölnlycke Health Care AB
- 10.3.5.1. Company overview
- 10.3.5.2. Financial performance
- 10.3.5.3. Product benchmarking
- 10.3.5.4. Strategic initiatives
- 10.3.6. ConvaTec Group PLC
- 10.3.6.1. Company overview
- 10.3.6.2. Financial performance
- 10.3.6.3. Product benchmarking
- 10.3.6.4. Strategic initiatives
- 10.3.7. Ethicon (Johnson & Johnson)
- 10.3.7.1. Company overview
- 10.3.7.2. Financial performance
- 10.3.7.3. Product benchmarking
- 10.3.7.4. Strategic initiatives
- 10.3.8. Baxter International
- 10.3.8.1. Company overview
- 10.3.8.2. Financial performance
- 10.3.8.3. Product benchmarking
- 10.3.8.4. Strategic initiatives
- 10.3.9. URGO Medical
- 10.3.9.1. Financial performance
- 10.3.9.2. Product benchmarking
- 10.3.9.3. Strategic initiatives
- 10.3.10. Coloplast Corp.
- 10.3.10.1. Company overview
- 10.3.10.2. Financial performance
- 10.3.10.3. Product benchmarking
- 10.3.10.4. Strategic initiatives
- 10.3.11. Medtronic
- 10.3.11.1. Company overview
- 10.3.11.2. Financial performance
- 10.3.11.3. Product benchmarking
- 10.3.11.4. Strategic initiatives
- 10.3.12. 3M
- 10.3.12.1. Company overview
- 10.3.12.2. Financial performance
- 10.3.12.3. Product benchmarking
- 10.3.12.4. Strategic initiatives
- 10.3.13. Derma Sciences (Integra LifeSciences)
- 10.3.13.1. Company overview
- 10.3.13.2. Financial performance
- 10.3.13.3. Product benchmarking
- 10.3.13.4. Strategic initiatives
- 10.3.14. Medline Industries, Inc.
- 10.3.14.1. Company overview
- 10.3.14.2. Financial performance
- 10.3.14.3. Product benchmarking
- 10.3.14.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook